Trials / Completed
CompletedNCT02373124
Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- New York State Psychiatric Institute · Academic / Other
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the feasibility of a treatment paradigm that involves naturalistic cocaine use opportunities in the context of psychotherapy aimed at utilizing these opportunities therapeutically.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | infusion of NMDA antagonist | 52 minute infusion |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2015-02-26
- Last updated
- 2020-02-05
- Results posted
- 2019-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02373124. Inclusion in this directory is not an endorsement.